RPRX · Royalty Pharma plc
$58.83
-0.19 (-0.32%)
At close · Jul 24
Market Cap
$33.88B
Shares
575.83M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-04 | — | |
| 8-K | 2026-05-28 | 2026-05-22 | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-06 | — | |
| 8-K | 2026-04-13 | — | |
| DEF 14A | 2026-04-10 | 2026-06-04 | |
| 8-K | 2026-02-11 | — | |
| 10-K | 2026-02-11 | 2025-12-31 | |
| Investor Event Transcript | 2025-12-31 | — | |
| 8-K | 2025-12-22 | 2025-12-20 | |
| 8-K | 2025-12-22 | 2025-12-19 | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-09-16 | — | |
| 8-K | 2025-08-13 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-07-17 | — | |
| 8-K | 2025-05-19 | 2025-05-16 | |
| 8-K | 2025-05-12 | — | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-04-11 | — | |
| 8-K | 2025-04-10 | 2025-04-07 | |
| 10-K | 2025-02-12 | 2024-12-31 | |
| 8-K | 2025-02-11 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2025-01-10 | — | |
| 8-K | 2025-01-10 | — | |
| 8-K | 2024-12-31 | — | |
| 8-K | 2024-11-06 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-09-27 | 2024-09-26 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-08-07 | 2024-08-06 | |
| 8-K | 2024-06-20 | 2024-06-17 | |
| 8-K | 2024-06-10 | — | |
| 8-K | 2024-06-06 | — | |
| 8-K | 2024-06-04 | 2024-06-03 | |
| 8-K | 2024-05-29 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-25 | 2024-06-06 | |
| 10-K | 2024-02-15 | 2023-12-31 | |
| 8-K | 2024-02-15 | — | |
| 8-K | 2024-02-06 | 2024-02-05 | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-12-27 | — |
Showing 1–50 of 109 filings
Key facts
CIK
1802768
CUSIP
G7709Q104
13F (30d)
111 filings
111 filers
Visit website
Investor relations